Biomind Labs Inc. Share Price OTC Markets
Equities
CRSWF
CA0907021012
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.11 USD | 0.00% | 0.00% | -89.00% |
Sales 2021 | - | Sales 2022 | - | Capitalization | 27.36M 2.19B |
---|---|---|---|---|---|
Net income 2021 | -4M -320M | Net income 2022 | -2M -160M | EV / Sales 2021 | - |
Net cash position 2021 | 2.23 178.42 | Net cash position 2022 | 0.02 1.44 | EV / Sales 2022 | - |
P/E ratio 2021 |
-17.8
x | P/E ratio 2022 |
-9.17
x | Employees | 5 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 60.21% |
Current month | -89.00% | ||
Current year | -89.00% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - | |
Oscar Leon
DFI | Director of Finance/CFO | - | - |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ravi Sood
CHM | Chairman | 48 | - |
Fraser Buchan
BRD | Director/Board Member | 40 | - |
Oscar Leon
DFI | Director of Finance/CFO | - | - |
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- BMND.F Stock
- CRSWF Stock